Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

Presentation TCT 2025

The Transformation of Diagnosis and Treatment of Coronary Artery Disease with FFRangio and the Road Ahead

Presenter: Martin B. Leon

October 26, 2025

Presentation TCT 2025

ARS 17: The Future of Medtech Innovation: Past to the Future

Presenter: Martin B. Leon

October 25, 2025

Presentation TCT 2025

ARS 16: The FDA and its Impact on MedTech Innovation

Presenter: Martin B. Leon

October 25, 2025

Presentation TCT 2025

ARS 15: Medtech at a Crossroads: Crisis, Optimism, and Opportunities

Presenter: Martin B. Leon

October 25, 2025

Presentation TCT 2025

ARS 26: Beyond Valvular Heart Interventions

Presenter: Martin B. Leon

October 25, 2025

Presentation TCT 2025

ARS 24: Technology Access in SHD Interventions

Presenter: Martin B. Leon

October 25, 2025

Podcast Rox Heart Radio

Rox Heart Radio: TCT 2025

October 15, 2025

News Industry News

Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe

August 01, 2025

Presentation NY Valves 2025

Intrepid (Medtronic)

Presenter: Martin B. Leon

June 26, 2025

Presentation NY Valves 2025

Expanding Clinical Indications and Future Trials

Presenter: Martin B. Leon

June 25, 2025

Presentation NY Valves 2025

Overview of AI-Driven Prediction in Structural Heart

Presenter: Martin B. Leon

June 25, 2025

News Daily News

Dimitrios Karmpaliotis, Master Operator and Mentor With ‘Heart of Gold,’ Dies at 53

Yael L. Maxwell

June 09, 2025

News Conference News EuroPCR 2025

Myval Noninferior to Other THVs at 1 Year, but Questions Persist

L.A. McKeown

May 21, 2025

News Conference News EuroPCR 2025

Early TAVI Improves Prognosis in Asymptomatic AS No Matter the Extent of Cardiac Damage

Yael L. Maxwell

May 21, 2025

News Features

What’s in a Name: Is It Time to Choose Between TAVI and TAVR?

Yael L. Maxwell

March 27, 2025

AZALEA-TIMI 71: Abelacimab Slashes Bleeds vs Rivaroxaban in AF, but Stroke Impact Unclear

News Conference News AHA 2023

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

L.A. McKeown

November 12, 2023

Partner Content

Studying the Clinical Impact of Restoring Native Flow with Biomimetic DurAVR® THV

June 6, 2025

Advertisement

The Transformation of Diagnosis and Treatment of Coronary Artery Disease with FFRangio and the Road Ahead

ARS 17: The Future of Medtech Innovation: Past to the Future

ARS 16: The FDA and its Impact on MedTech Innovation

ARS 15: Medtech at a Crossroads: Crisis, Optimism, and Opportunities

ARS 26: Beyond Valvular Heart Interventions

ARS 24: Technology Access in SHD Interventions

Rox Heart Radio: TCT 2025

Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe

Intrepid (Medtronic)

Expanding Clinical Indications and Future Trials

Overview of AI-Driven Prediction in Structural Heart

Dimitrios Karmpaliotis, Master Operator and Mentor With ‘Heart of Gold,’ Dies at 53

Myval Noninferior to Other THVs at 1 Year, but Questions Persist

Early TAVI Improves Prognosis in Asymptomatic AS No Matter the Extent of Cardiac Damage

What’s in a Name: Is It Time to Choose Between TAVI and TAVR?

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

Studying the Clinical Impact of Restoring Native Flow with Biomimetic DurAVR® THV

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content